Beta Bionics, Inc. (BBNX) stock
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/304% below fair value
$14.72−0.49 (-3.22%)
Close on Nov 17, 2026Market cap $800.28MP/E –Yield –
Beta Bionics cash
Cash and short-term investments held at the end of each period.
Beta Bionics's cash was $240.20M at Sep 30, 2026. For fiscal 2025 it was $219.13M, up 111.4% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $219.13M | +111.4% |
| FY2024 | Dec 31, 2024 | $103.68M | +7.1% |
| FY2023 | Dec 31, 2023 | $96.85M | +248.7% |
| FY2022 | Dec 31, 2022 | $27.78M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $240.20M | +5.0% |
| Q2 FY2026 | Jun 30, 2026 | $180.49M | -27.7% |
| Q1 FY2026 | Mar 31, 2026 | $199.52M | -13.8% |
| Q4 FY2025 | Dec 31, 2025 | $219.13M | +111.4% |
| Q3 FY2025 | Sep 30, 2025 | $228.69M | +1208.2% |
| Q2 FY2025 | Jun 30, 2025 | $249.72M | +1816.6% |
| Q1 FY2025 | Mar 31, 2025 | $231.47M | +948.7% |
| Q4 FY2024 | Dec 31, 2024 | $103.68M | +7.1% |
| Q3 FY2024 | Sep 30, 2024 | $17.48M | -37.1% |
| Q2 FY2024 | Jun 30, 2024 | $13.03M | – |
| Q1 FY2024 | Mar 31, 2024 | $22.07M | – |
| Q4 FY2023 | Dec 31, 2023 | $96.85M | – |
| Q4 FY2022 | Dec 31, 2022 | $27.78M | – |
See a number that looks wrong?